| 标题 |
Amivantamab plus chemotherapy vs. chemotherapy as first-line treatment in Chinese mainland patients with EGFR exon 20 insertion non-small cell lung cancer: Subgroup analysis of the randomized PAPILLON trial |
| 网址 | |
| DOI |
10.1097/cm9.0000000000004134
doi
|
| 其它 |
期刊:Chinese Medical Journal 作者:Ke Tang; Fengying Wu; Fang Yang; Yu Yao; Y W Zhao; et al 出版日期:2026-05-26 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)